| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Immunology (Y.A., M.S., C.R.-M., A.L.-M., R.P.-B.) and Endocrinology (A.L.-M.) Divisions, University Hospital Germans Trias i Pujol, Badalona, 08916 Barcelona; and Almirall-Prodesfarma Research Center (Y.A., O.D.), 08980 Barcelona, Spain
Address all correspondence and requests for reprints to: Prof. R. Pujol-Borrell, Immunology Unit, University Hospital Germans Trias i Pujol, Carretera. del Canyet s/n, Badalona, 08916 Barcelona, Spain. E-mail: ricardo.pujol{at}uab.es
An adaptation of mixed oligonucleotide primed amplification of
complementary DNA to detect the profile of CC chemokines in biological
samples is presented. By introducing normalization, two correction
coefficients, performing a single amplification reaction, and five
parallel hybridizations, intrasample and intersample comparisons can be
reliably made. This protocol of single tube PCR CC chemokine profiling
was applied to tissue samples from an autoimmune thyroid condition,
Graves disease, and from a nonautoimmune condition, multinodular
goiter. Results demonstrate overexpression of CC chemokines in Graves
disease, statistically significant for macrophage inflammatory
protein-1
and -1ß, which correlated with the aberrant human
leukocyte antigen class II expression by thyrocytes, as assessed by
flow cytometry. Overexpression of CC chemokines probably plays a major
role in determining the characteristics of the lymphocytes migrating to
the thyroid gland and influences the course of the disease. The study
of chemokine profile should be more informative than the study of
isolated chemokines and cytokines, and as it can be applied to fine
needle aspiration biopsies, it may be useful to clinical research.
This article has been cited by other articles:
![]() |
A. Antonelli, C. Ferri, P. Fallahi, S. M. Ferrari, D. Giuggioli, M. Colaci, A. Manfredi, S. Frascerra, F. Franzoni, F. Galetta, et al. CXCL10 ({alpha}) and CCL2 ( ) chemokines in systemic sclerosis a longitudinal study Rheumatology, January 1, 2008; 47(1): 45 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani Role of Chemokines in Endocrine Autoimmune Diseases Endocr. Rev., August 1, 2007; 28(5): 492 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antonelli, P. Fallahi, M. Rotondi, S. M. Ferrari, P. Romagnani, M. Grosso, E. Ferrannini, and M. Serio Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. Eur. J. Endocrinol., May 1, 2006; 154(5): 651 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antonelli, M. Rotondi, P. Fallahi, P. Romagnani, S. M. Ferrari, A. Paolicchi, E. Ferrannini, and M. Serio Increase of interferon-{gamma} inducible {alpha} chemokine CXCL10 but not {beta} chemokine CCL2 serum levels in chronic autoimmune thyroiditis Eur. J. Endocrinol., February 1, 2005; 152(2): 171 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Martin, E. C. Coronel, G.-i. Sano, S.-C. Chen, G. Vassileva, C. Canasto-Chibuque, J. D. Sedgwick, P. S. Frenette, M. Lipp, G. C. Furtado, et al. A Novel Model for Lymphocytic Infiltration of the Thyroid Gland Generated by Transgenic Expression of the CC Chemokine CCL21 J. Immunol., October 15, 2004; 173(8): 4791 - 4798. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-P. Armengol, C. B. Cardoso-Schmidt, M. Fernandez, X. Ferrer, R. Pujol-Borrell, and M. Juan Chemokines Determine Local Lymphoneogenesis and a Reduction of Circulating CXCR4+ T and CCR7 B and T Lymphocytes in Thyroid Autoimmune Diseases J. Immunol., June 15, 2003; 170(12): 6320 - 6328. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Romagnani, M. Rotondi, E. Lazzeri, L. Lasagni, M. Francalanci, A. Buonamano, S. Milani, P. Vitti, L. Chiovato, M. Tonacchera, et al. Expression of IP-10/CXCL10 and MIG/CXCL9 in the Thyroid and Increased Levels of IP-10/CXCL10 in the Serum of Patients with Recent-Onset Graves' Disease Am. J. Pathol., July 1, 2002; 161(1): 195 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Imaizumi, A. Pritsker, P. Unger, and T. F. Davies Intrathyroidal Fetal Microchimerism in Pregnancy and Postpartum Endocrinology, January 1, 2002; 143(1): 247 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. GarcIa-Lopez, D. Sancho, F. Sanchez-Madrid, and M. Marazuela Thyrocytes from Autoimmune Thyroid Disorders Produce the Chemokines IP-10 And Mig and Attract CXCR3+ Lymphocytes J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5008 - 5016. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Simchen, I. Lehmann, D. Sittig, M. Steinert, and G. Aust Expression and Regulation of Regulated on Activation, Normal T Cells Expressed and Secreted in Thyroid Tissue of Patients with Graves' Disease and Thyroid Autonomy and in Thyroid-Derived Cell Populations J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4758 - 4764. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |